… Endotherapy is now the mainstay of therapy for Barrett's … and assessment of patients with
Barrett's esophagus (BE). Endoscopic … Patients with non-dysplastic Barrett's require further risk …

… for Barrett's esophagus with high-grade dysplasia and intramucosal cancer. Endotherapy is
… the efficacy and safety of endotherapy and surgery for treatment of early Barrett's neoplasia. …

The annual incidence of adenocarcinoma arising in the setting of Barrett’s esophagus (BE)
is approximately 0.5%. 1–3 Adenocarcinoma related to BE develops by a process of gradual …

… of lymph node metastasis, endotherapy has become an … Endotherapy should be considered
primary therapy for appropriate patients with low-risk lesions. Complete Barrett's esophagus …

… on endotherapy in the setting of non-dysplastic Barrett ’ s and … strong recommendations in
terms of endotherapy for Barrett ’ s: (i) … endotherapy for the general population of nondysplastic …

… endotherapies in the care of patients with early cancer or high‐grade dysplasia of Barrett's
oesophagus … No ongoing trials that compared surgery to endotherapy in Barrett's oesophagus …

… Barrett's oesophagus (BO) is thought to progress through the … Barrett's oesophagus(BO) is
the strongest risk factor for and precursor … challenges during and following endotherapy for BO. …

… This review highlights the potential complications associated with BE endotherapy and the
… study of patients who developed bleeding following endotherapy (not limited to BE) reported …

… Both endotherapy and esophagectomy can effectively treat high-grade dysplasia and
intramucosal carcinoma associated with Barrett's esophagus. Endotherapy is associated with a …

… Barrett's esophagus (BE) is a condition in which the normal esophageal squamous epithelium
is replaced by specialized intestinal metaplasia. This condition is thought to develop when …